Value proposition

We turn science into medicine.

Angiolutions – breaking new ground in abdominal aortic aneurysm (AAA) treatment.

Abdominal aortic aneurysms are threatening the lives of millions of patients around the world with no way to intercept early disease progression.

Angiolutions will change that.

Angiolutions is the first company to develop a therapeutic device preventing disease progression in small abdominal aortic aneurysms.